These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10888386)

  • 1. Both low and high energy cardioversion induced accelerated ventricular tachycardia in a patient treated with an implantable cardioverter defibrillator.
    Washizuka T; Chinushi M; Hatada K; Kasai H; Ohhira K; Furushima H; Aizawa Y
    Jpn Heart J; 1999 Sep; 40(5):665-9. PubMed ID: 10888386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.
    Chinushi M; Aizawa Y; Higuchi K
    Heart; 1997 Apr; 77(4):373-4. PubMed ID: 9155621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease.
    Lauer MR; Young C; Liem LB; Ottoboni L; Peterson J; Goold P; Sung RJ
    Am J Cardiol; 1994 Mar; 73(8):559-63. PubMed ID: 8147300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator.
    Grimm W; Flores BF; Marchlinski FE
    Am J Cardiol; 1993 Jun; 71(16):1415-8. PubMed ID: 8517386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator.
    Wolpert C; Kuschyk J; Aramin N; Spehl S; Streitner F; Süselbeck T; Schumacher B; Haase KK; Schimpf R; Borggrefe M
    Heart; 2004 Jun; 90(6):667-71. PubMed ID: 15145875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
    van Opstal J; Geskes G; Debie L
    Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
    Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group.
    Hammill SC; Packer DL; Stanton MS; Fetter J
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 1):3-10. PubMed ID: 7700828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
    Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia converts to sinus rhythm after administration of propofol.
    Shannon K; Saltzman D; Li I; Mokszycki R; Galletta G
    Am J Emerg Med; 2021 Oct; 48():377.e1-377.e3. PubMed ID: 33875319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
    Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
    Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
    Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.